3 months progress oral 0.5 duta + 2.5 minoxodil Progress Pictures 8/17/2026
The user shared progress pictures after 3 months of using oral dutasteride (0.5 mg) and minoxidil (2.5 mg), along with a derma roller and topical GHK-Cu serum. They noticed baby hairs growing and received advice to wait for further results, consider using a Dr. Pen instead of a derma roller, and check for scalp inflammation.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Has been on minoxidil for 5 years. Microneedling for 4 weeks no results.
The user has used minoxidil for five years and added microneedling for four weeks without seeing results. They are considering a hair transplant but are advised that hair loss will persist without a DHT blocker.
community My personal experience/observations fighting AGA seriously for 5 years
Minoxidil with alcohol and propylene glycol was more effective than non-alcohol versions, and RU58841 worked best in a non-water-based solution. Oral finasteride showed better results than topical, despite side effects; microneedling and tretinoin worsened hair loss, and PRP was only helpful when younger.
community Do not switch from topical to oral minoxidil.
Switching from topical to oral minoxidil caused prolonged hair shedding without regrowth, leading to the use of both topical and oral minoxidil with oral finasteride. Responses to these treatments vary, emphasizing the need for personalized approaches.
community Seeing some progress but looking for advice
The user has been using 1mg oral finasteride and topical minoxidil for a year and is considering switching to dutasteride or adding a derma roller to improve hair thickness. Suggestions include switching to oral minoxidil, adding microneedling, scalp massages, and possibly using a derma pen or tretinoin for better results.
community The last and most important part of my hairloss treatment stack. (Dutasteride and leaving this community)
The user successfully improved their hair from Norwood 3 to 0.5 using finasteride, topical minoxidil, microneedling, and a hair peptide, and plans to maintain it with dutasteride. They are leaving the forum due to emotional distress caused by the community.
Related Research
6 / 6 resultsresearch A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
research An Updated Etiology of Hair Loss and the New Cosmeceutical Paradigm in Therapy: Clearing ‘the Big Eight Strikes’
This review concluded that the efficacy of cosmeceutical hair serums for addressing hair loss lies in their use of bioactive peptides and plant compounds, like flavonoids and sterols, that target eight key contributing factors identified in hair loss conditions.
research A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials
This review discusses the potential of GHK-Cu delivery via microneedle platforms for skin conditions and notes the need for well-designed human trials to translate preclinical evidence into clinical practice.
research Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia.
Combining microneedling with drugs and stem cells shows promise for improving hair growth in androgenetic alopecia.
research Novel Treatment Modalities for Hair Loss
This review discusses novel treatments for androgenetic alopecia, including therapies like platelet-rich plasma and adipose-derived stem cells, and reports no new clinical results.
research Female Androgenetic Alopecia: An Update on Diagnosis and Management
This review discusses female androgenetic alopecia, highlighting its diagnostic challenges and management strategies, but it reports no new results.